InsiderDirector

ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed Insider Trading Activity

Every SEC Form 4 transaction reported by ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed, sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Is ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed buying or selling?

ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed reported 93 open-market buys ($672.4M) and 123 sells ($1.1B) across 216 Form 4 filings at 59 companies — a net selling position of $445.8M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 9, 2026)

Total Form 4 filings
216
SEC EDGAR
Companies
59
Buys (93)
$672.4M
Sells (123)
$1.1B

Insider sentiment

Net selling

Net insider flow of $445.8M in net selling, filed between May 2, 2018 – Jul 9, 2026.

Companies ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed files for

#CompanyForm 4 filings
1PASGPassage BIO, Inc.17
2SIONSionna Therapeutics, Inc.11
3ALECAlector, Inc.10
4INSPInspire Medical Systems, Inc.9
5SWTXSpringWorks Therapeutics, Inc.9
6IRONDisc Medicine, Inc.8
7NPCENeuroPace Inc8
8DMRAGalecto, Inc.7
9CMPXCompass Therapeutics, Inc.6
10ELVNEnliven Therapeutics, Inc.6

Recent ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed transactions

DateTickerRoleTypeSharesValue
Jul 9, 2026SIONDirectorSale85.9K$3.9M
Jul 2, 2026SIONDirectorSale115.8K$5.3M
Jun 24, 2026ELVN10% OwnerSale860.1K$39.0M
Jun 17, 2026ELVN10% OwnerSale281.4K$12.7M
Jun 2, 2026QTTBDirector, 10% OwnerPurchase1.9M$15.0M
May 30, 2026SIONDirectorSale101$4.5K
May 11, 2026SIONDirectorSale293.0K$13.4M
Apr 29, 2026TRAW10% OwnerPurchase597.7K$998.2K
Apr 23, 2026PRLDDirector, 10% OwnerPurchase2.8M$12.5M
Apr 22, 2026SIONDirectorSale55.3K$2.5M
Apr 16, 2026SIONDirectorSale510.6K$22.9M
Apr 9, 2026ACET10% OwnerSale104.7K$674.8K
Feb 5, 2026SIONDirectorSale31.0K$1.4M
Dec 30, 2025SIONDirectorSale33.4K$1.5M
Dec 20, 2025SIONDirectorSale1.9K$83.4K
Nov 26, 2025SIONDirectorSale108.1K$4.8M
Oct 27, 2025PMVP10% OwnerSale1.0M$1.5M
Oct 11, 2025ACET10% OwnerPurchase5.0M$5.0M
Sep 12, 2025PMVP10% OwnerSale500.0K$900.0K
Sep 3, 2025STTKDirectorPurchase6.3M$5.5M
Jul 2, 2025CRVSDirector, 10% OwnerSale1.2M$4.9M
Jun 26, 2025PASG10% OwnerSale583.7K$197.2K
May 16, 2025NPCE10% OwnerSale168.1K$2.7M
Apr 24, 2025PASG10% OwnerSale235.6K$78.7K
Apr 17, 2025PASG10% OwnerSale149.1K$49.7K

Showing the 25 most recent filings of 216. Screen every filing.

ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed insider trading FAQ

Is ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed buying or selling?

Across 216 SEC Form 4 filings, ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed reported 93 open-market purchases totaling $672.4M and 123 sales totaling $1.1B — a net selling position of $445.8M.

Which companies does ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed file Form 4s for?

ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed has reported insider transactions at 59 companies, most often Passage BIO, Inc. (PASG), Sionna Therapeutics, Inc. (SION), Alector, Inc. (ALEC), Inspire Medical Systems, Inc. (INSP), SpringWorks Therapeutics, Inc. (SWTX).

How far back does ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed's filing history go?

Trabud holds ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed's SEC Form 4 filings from May 2, 2018 – Jul 9, 2026, sourced directly from SEC EDGAR.

Where does Trabud get ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track ORBIMED ADVISORS LLC / Capital GP Viii Llc Orbimed and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener